Careras, Rosenda L.
HRN: 23-08-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2024
MUPIROCIN 2%, 15G (TUBE)
09/02/2024
09/08/2024
TOPICAL
Apply On Affected Areas
Bid
Ij Site Prophylaxis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes